Author:
Gerami Reza,Agahi Tahereh,Barkhordari Shoresh,Kargar Jalal
Abstract
Abstract
Background
NTD is one of the most important problems of the nervous system and the second fetal anomaly that is associated with high mortality and morbidity. Therefore, its prenatal diagnosis is very important. AFP has a high false positive, which reduces its diagnostic value, so the discovery of ultrasound findings in OSB is very important and can replace AFP testing.
Results
4 patients with positive OSB were detected and their diagnosis was confirmed during pathological follow-up (100% diagnostic accuracy) and the rest of the patients with high AFP (51 patients) were negative for OSB. Therefore, the diagnostic accuracy of AFP during statistical analysis was about 7%, which is a very low value.
Conclusion
According to the results of this study, IT, BS, BSOB, BS/BSOB ultrasound criteria in the first screening and decreased BPD and ventriculomegaly in the second screening ultrasound in OSB diagnosis have a higher diagnostic value than the AFP laboratory level. It should pay more attention to MS-AFP results in OSB screening.
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging
Reference24 articles.
1. Williams J, Mai CT, Mulinare J, Isenburg J, Flood TJ, Ethen M et al (2015) Updated estimates of neural tube defects prevented by mandatory folic acid fortification—United States, 1995–2011. MMWR Morb Mortal Wkly Rep 64(1):1
2. Corroenne R, Zhu K, Orman G, Huisman T, Mehollin-Ray AR, Johnson E et al (2021) Maternal serum alpha-fetoprotein level and the relationship to ventriculomegaly in fetal neural tube defect: a retrospective cohort study. Eur J Obstet Gynecol Reprod Biol 259:185–190
3. Haddow J, Macri J, Munson M (1979) The amnion regulates movement of fetally derived alpha-fetoprotein into maternal blood. J Lab Clin Med 94(2):344–347
4. Christiansen M, Høgdall CK, Høgdall EV (2000) Alpha-fetoprotein in human fetal cerebrospinal fluid. Clin Chim Acta 291(1):35–41
5. Krause TG, Christens P, Wohlfahrt J, Lei U, Westergaard T, Nørgaard-Pedersen B et al (2001) Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcome. Obstet Gynecol 97(2):277–282